These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 8014475)
1. Cathepsin B activity in human lung tumor cell lines: ultrastructural localization, pH sensitivity, and inhibitor status at the cellular level. Spiess E; Brüning A; Gack S; Ulbricht B; Spring H; Trefz G; Ebert W J Histochem Cytochem; 1994 Jul; 42(7):917-29. PubMed ID: 8014475 [TBL] [Abstract][Full Text] [Related]
2. Localization of cathepsin B in two human lung cancer cell lines. Erdel M; Trefz G; Spiess E; Habermaas S; Spring H; Lah T; Ebert W J Histochem Cytochem; 1990 Sep; 38(9):1313-21. PubMed ID: 2201737 [TBL] [Abstract][Full Text] [Related]
3. Differential localization of cysteine protease inhibitors and a target cysteine protease, cathepsin B, by immuno-confocal microscopy. Calkins CC; Sameni M; Koblinski J; Sloane BF; Moin K J Histochem Cytochem; 1998 Jun; 46(6):745-51. PubMed ID: 9603786 [TBL] [Abstract][Full Text] [Related]
4. Cathepsin B and cysteine proteinase inhibitors in human lung cancer cell lines. Heidtmann HH; Salge U; Abrahamson M; Bencina M; Kastelic L; Kopitar-Jerala N; Turk V; Lah TT Clin Exp Metastasis; 1997 Jul; 15(4):368-81. PubMed ID: 9219725 [TBL] [Abstract][Full Text] [Related]
6. Toward understanding recurrent meningioma: the potential role of lysosomal cysteine proteases and their inhibitors. Lah TT; Nanni I; Trinkaus M; Metellus P; Dussert C; De Ridder L; Rajcević U; Blejec A; Martin PM J Neurosurg; 2010 May; 112(5):940-50. PubMed ID: 19747051 [TBL] [Abstract][Full Text] [Related]
7. Prognostic value of cathepsins B, H, L, D and their endogenous inhibitors stefins A and B in head and neck carcinoma. Budihna M; Strojan P; Smid L; Skrk J; Vrhovec I; Zupevc A; Rudolf Z; Zargi M; Krasovec M; Svetic B; Kopitar-Jerala N; Kos J Biol Chem Hoppe Seyler; 1996 Jun; 377(6):385-90. PubMed ID: 8839984 [TBL] [Abstract][Full Text] [Related]
8. Functional characterization of a cystatin A from the bat Myotis davidii. Costa GCA; Torquato RJS; de Morais Gomes V; Rosa-Fernandes L; Palmisano G; Tanaka AS Comp Biochem Physiol B Biochem Mol Biol; 2024; 274():111003. PubMed ID: 38936799 [TBL] [Abstract][Full Text] [Related]
9. Differences in specificity for the interactions of stefins A, B and D with cysteine proteinases. Lenarcic B; Krizaj I; Zunec P; Turk V FEBS Lett; 1996 Oct; 395(2-3):113-8. PubMed ID: 8898076 [TBL] [Abstract][Full Text] [Related]
10. Cathepsin B fraction active at physiological pH of 7.5 is of prognostic significance in squamous cell carcinoma of human lung. Werle B; Jülke B; Lah T; Spiess E; Ebert W Br J Cancer; 1997; 75(8):1137-43. PubMed ID: 9099961 [TBL] [Abstract][Full Text] [Related]
11. Grafting of features of cystatins C or B into the N-terminal region or second binding loop of cystatin A (stefin A) substantially enhances inhibition of cysteine proteinases. Pavlova A; Björk I Biochemistry; 2003 Sep; 42(38):11326-33. PubMed ID: 14503883 [TBL] [Abstract][Full Text] [Related]
12. The amino acid sequences, structure comparisons and inhibition kinetics of sheep cathepsin L and sheep stefin B. Ritonja A; Coetzer TH; Pike RN; Dennison C Comp Biochem Physiol B Biochem Mol Biol; 1996 Jun; 114(2):193-8. PubMed ID: 8759291 [TBL] [Abstract][Full Text] [Related]
13. Selective Neutral pH Inhibitor of Cathepsin B Designed Based on Cleavage Preferences at Cytosolic and Lysosomal pH Conditions. Yoon MC; Solania A; Jiang Z; Christy MP; Podvin S; Mosier C; Lietz CB; Ito G; Gerwick WH; Wolan DW; Hook G; O'Donoghue AJ; Hook V ACS Chem Biol; 2021 Sep; 16(9):1628-1643. PubMed ID: 34416110 [TBL] [Abstract][Full Text] [Related]
14. Cathepsin B in infiltrated lymph nodes is of prognostic significance for patients with nonsmall cell lung carcinoma. Werle B; Kraft C; Lah TT; Kos J; Schanzenbächer U; Kayser K; Ebert W; Spiess E Cancer; 2000 Dec; 89(11):2282-91. PubMed ID: 11147599 [TBL] [Abstract][Full Text] [Related]
15. Human recombinant pro-dipeptidyl peptidase I (cathepsin C) can be activated by cathepsins L and S but not by autocatalytic processing. Dahl SW; Halkier T; Lauritzen C; Dolenc I; Pedersen J; Turk V; Turk B Biochemistry; 2001 Feb; 40(6):1671-8. PubMed ID: 11327826 [TBL] [Abstract][Full Text] [Related]
16. Human cysteine proteinases and their protein inhibitors stefins, cystatins and kininogens. Turk V; Brzin J; Kotnik M; Lenarcic B; Popović T; Ritonja A; Trstenjak M; Begić-Odobasić L; Machleidt W Biomed Biochim Acta; 1986; 45(11-12):1375-84. PubMed ID: 3495261 [TBL] [Abstract][Full Text] [Related]
17. Cathepsin B in cells of two rat sarcomas with different rates of spontaneous metastasis. Krepela E; Veselý P; Chaloupková A; Zicha D; Urbanec P; Rasnick D; Vicar J Neoplasma; 1989; 36(5):529-40. PubMed ID: 2812149 [TBL] [Abstract][Full Text] [Related]
18. Elongation on the amino-terminal part of stefin B decreases inhibition of cathepsin H. Jerala R; Kroon-Zitko L; Popovic T; Turk V Eur J Biochem; 1994 Sep; 224(3):797-802. PubMed ID: 7925405 [TBL] [Abstract][Full Text] [Related]
19. Primary tumour expression of the cysteine cathepsin inhibitor Stefin A inhibits distant metastasis in breast cancer. Parker BS; Ciocca DR; Bidwell BN; Gago FE; Fanelli MA; George J; Slavin JL; Möller A; Steel R; Pouliot N; Eckhardt B; Henderson MA; Anderson RL J Pathol; 2008 Feb; 214(3):337-46. PubMed ID: 17985332 [TBL] [Abstract][Full Text] [Related]
20. Molecular mechanism of inhibition of cysteine proteinases by their protein inhibitors: kinetic studies with natural and recombinant variants of cystatins and stefins. Machleidt W; Thiele U; Assfalg-Machleidt I; Förger D; Auerswald EA Biomed Biochim Acta; 1991; 50(4-6):613-20. PubMed ID: 1801731 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]